FRET as the tool for in vivo nanomedicine tracking - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Controlled Release Année : 2022

FRET as the tool for in vivo nanomedicine tracking

(1) , (1) , (1)


Advanced drug delivery system utilizing a nanocarrier is the major application of nanotechnology on pharmacotherapeutics. However, despite the promising benefits and a leading trend in pharmaceutical research, nanomedicine development suffers from a poor clinical translation problem as only a handful of nanomedicine products reach the market yearly. The conventional pharmacokinetic study generally focuses only on monitoring the level of a free drug but ignores the nanocarrier's role in pharmacokinetics. One hurdle is that it is difficult to directly track intact nanocarriers in vivo to explore their pharmacokinetics. Although several imaging techniques such as radiolabeling, nuclear imaging, fluorescence imaging, etc., have been developed over the past few years, currently, one method that can successfully track the intact nanocarriers in vivo directly is by Förster resonance energy transfer (FRET). This review summarizes the application of FRET as the in vivo nanoparticle tracker for studying the in vivo pharmacokinetics of the organic nanocarriers and gives elaborative details on the techniques utilized.
Fichier principal
Vignette du fichier
2022-Kaekhamloed_FRET as the tool for the in vivo nanomedicine tracking.pdf (5.38 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03720790 , version 1 (12-07-2022)


Paternité - Pas d'utilisation commerciale - Pas de modification - CC BY 4.0



Norraseth Kaeokhamloed, Samuel Legeay, Emilie Roger. FRET as the tool for in vivo nanomedicine tracking. Journal of Controlled Release, 2022, 349, pp.156-173. ⟨10.1016/j.jconrel.2022.06.048⟩. ⟨hal-03720790⟩
21 Consultations
12 Téléchargements



Gmail Facebook Twitter LinkedIn More